| Filed On | Filing |
|---|---|
| 04 Feb 2026 |
Form 3/A: Herrera Jaqueline, Director
Holds 2,900 shares of Common Shares |
| 23 Aug 2024 |
Form 3/A: Drera Saleem, VP Radioisotopes, Radiological
Holds 266,595 shares of Common Shares |
| 23 Jan 2020 |
Form 3/A: Tarnowski Matthew, Chief Accounting Officer and
Holds 56,595 shares of Common Shares |
| 02 May 2019 |
Form 3/A: Eshleman Benjamin Iii, Director
Holds 3,500 shares of Common Shares |
| 08 Jan 2019 |
Form 3/A: Eshleman Benjamin Iii, Director
Holds 2,887,304 shares of Common Shares |
| 06 Jun 2018 |
Form 3/A: Bovaird J. Birks, Director
Holds 11,599 shares of Common Shares |
| 29 Mar 2018 |
Form 3/A: Tarnowski Matthew, Chief Accounting Officer and
Holds 60,173 shares of Common Shares |
| 21 Aug 2017 |
Form 3/A: Antony Stephen P., Director
Holds 107,852 shares of Common Shares |
| 17 Mar 2017 |
Form 3/A: Higgs Dennis Lyle, Director
Holds 573,787 shares of Common Shares |
| 15 Mar 2017 |
Form 3/A: Antony Stephen P., Director
Holds 140,595 shares of Common Shares |
| 07 Jul 2016 |
Form 3/A: Chalmers Mark, Chief Operating Officer
No securities owned |
| 23 Mar 2016 |
Form 3/A: Catchpole Glenn, Director
Holds 467,259 shares of Common Shares |
Loading...